Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
This study evaluated the safety and effectiveness of Atomoxetine for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including AichiThis study evaluated the effectiveness of Atomoxetine for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Gothenburg
Attention Deficit/Hyperactivity Disorder (ADHD) Internet Survey Study in a College Student Population
This study has finished and is no longer accepting participants.
In Winston-SalemA Placebo-controlled Trial of Brain Activity Changes Following Psychostimulant Medication in Adolescent Combined-subtype ADHD
This study has finished and is no longer accepting participants.
In Hartford
Randomized Controlled Trial of Executive Function Training in Children With or At-risk for Attention-Deficit/Hyperactivity Disorder (ADHD) and Executive Function (EF) Impairment
This study has finished and is no longer accepting participants.
In StanfordAn In Depth Cardiovascular Study of Lisdexamfetamine (LDX; Vyvanse) in Healthy and Treated Hypertensive Adults With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In CambridgeRandomized-controlled Trial of a Classroom-based Distance Intervention for Teachers of Elementary School-aged Children With ADHD
This study has finished and is no longer accepting participants.
In HalifaxResearchers compared Prospekta and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including BryanskThis study has finished and is no longer accepting participants.
In ParisThis study evaluated the safety and effectiveness of Atomoxetine Hydrochloride for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including ShanghaiA Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride and Placebo in Child and Adolescent Outpatients With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including WallsendA Randomized, Double-Blind, Crossover Comparison of Atomoxetine and Placebo in Child Outpatients With Attention-Deficit/Hyperactivity Disorder, Reading Disorder, or Comorbid Attention-Deficit/Hyperactivity Disorder and Reading Disorder.
This study has finished and is no longer accepting participants.
Multiple locations, including GhentWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.